Insulin Access Enhancement in India: Expert Views on Integrating Interchangeable Biosimilar Insulin Glargine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insulin Access Enhancement in India: Expert Views on Integrating Interchangeable Biosimilar Insulin Glargine

Published:2024-05-24 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Prasanna Kumar KM,Chowdhury Subhankar,Bantwal Ganapathi,Unnikrishnan A G,Kalra Sanjay,Aggarwal Sameer,Singh Awadhesh Kumar,Pandit Kaushik,Shukla Rishi,Vishwanathan Vijay,Khobragade Kunal,Sarda Prashant S

Publisher

Springer Science and Business Media LLC

Reference53 articles.

1. Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia;Sendekie AK;PLoS One,2022

2. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi SE;Diabetes Care,2015

3. Insulin prices, availability and affordability in 13 low-income and middle-income countries;Ewen M;BMJ Global Health,2019

4. A global perspective on the issue of access to insulin;Beran D;Diabetologia,2021

5. WHO. Keeping the 100-year-old promise: Making insulin access universal. (2021). Accessed: October 23, 2023: https://iris.who.int/bitstream/handle/10665/348384/9789240039100-eng.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP